RENEE MARCHEGIANI DO
Prescription History 1982192282
Anesthesiology - Pain Medicine in Wasilla, AK


Quality Rating: 77.52 out of 100 score

NPI Status: Active since April 23, 2018

Contact Information

3190 E MERIDIAN PARK LOOP STE 207
WASILLA, AK
ZIP 99654
Phone: (907) 373-9460
Fax: (907) 373-9461

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for RENEE MARCHEGIANI DO, an active Pain Medicine specialist practicing in Wasilla, AK. Our medical registry currently tracks 22 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,271 documented patient claims. Among these therapy options, the most frequently utilized medication is Gabapentin, which accounts for 201 claims alone.


Acetaminophen-Codeine

Generic Formulation: Acetaminophen With CodeineSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 29
30-Day Fills 29.0
Days Supply 578
AK State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills26.4
Peer Average Days Supply543
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $375.29 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.94

State Avg Cost Per Claim

$21.30

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

See also Warning section. This combination medication is used to help relieve mild to moderate pain. It contains an opioid pain reliever (codeine) and a non-opioid pain reliever (acetaminophen). Codeine works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Amitriptyline Hcl

Generic Formulation: Amitriptyline HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 39
30-Day Fills 59.0
Days Supply 1,770
AK State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills31.3
Peer Average Days Supply891
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 105.3% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $501.76 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.87

State Avg Cost Per Claim

$22.09

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat mental/mood problems such as depression. It may help improve mood and feelings of well-being, relieve anxiety and tension, help you sleep better, and increase your energy level. This medication belongs to a class of medications called tricyclic antidepressants. It works by affecting the balance of certain natural chemicals (neurotransmitters such as serotonin) in the brain.

Baclofen

Generic Formulation: BaclofenSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 75
30-Day Fills 92.0
Days Supply 2,760
AK State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills32.5
Peer Average Days Supply796
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 177.8% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,395.35 across this reporting matrix range.

Provider Avg Cost Per Claim

$31.94

State Avg Cost Per Claim

$26.63

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.

Therapeutic Applications

Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). It works by helping to relax the muscles.

Celecoxib

Generic Formulation: CelecoxibSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 15
30-Day Fills 19.0
Days Supply 570
AK State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills45.8
Peer Average Days Supply1,319
Conservative Utilization

This provider writes prescriptions for this formulation 42.3% less frequently than the standard regional baseline metric for practitioners inside AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $380.76 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.38

State Avg Cost Per Claim

$49.57

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN.

Therapeutic Applications

This medication is a nonsteroidal anti-inflammatory drug (NSAID), specifically a COX-2 inhibitor, which relieves pain and swelling (inflammation). It is used to treat arthritis, acute pain, and menstrual pain and discomfort. The pain and swelling relief provided by this medication helps you perform more of your normal daily activities. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. This drug works by blocking the enzyme in your body that makes prostaglandins. Decreasing prostaglandins helps to reduce pain and swelling.

Cyclobenzaprine Hcl

Generic Formulation: Cyclobenzaprine HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 52
30-Day Fills 58.0
Days Supply 1,652
AK State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills30.7
Peer Average Days Supply745
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 100.0% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $546.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.52

State Avg Cost Per Claim

$14.80

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Cyclobenzaprine is used short-term to treat muscle spasms. It is usually used along with rest and physical therapy. It works by helping to relax the muscles. This medication is not recommended for use in older adults because they may be at greater risk for side effects while using this drug. Ask the doctor or pharmacist for details.

Diclofenac Sodium

Generic Formulation: Diclofenac SodiumSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 76
30-Day Fills 76.4
Days Supply 1,824
AK State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills32.0
Peer Average Days Supply622
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 181.5% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,690.18 across this reporting matrix range.

Provider Avg Cost Per Claim

$35.40

State Avg Cost Per Claim

$35.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.

Therapeutic Applications

See also Warning section. This medication is used to relieve joint pain from arthritis. Diclofenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain.

Duloxetine Hcl

Generic Formulation: Duloxetine HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 23
30-Day Fills 25.0
Days Supply 750
AK State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills57.6
Peer Average Days Supply1,555
Conservative Utilization

This provider writes prescriptions for this formulation 36.1% less frequently than the standard regional baseline metric for practitioners inside AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $403.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.54

State Avg Cost Per Claim

$40.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA.

Therapeutic Applications

Duloxetine is used to treat depression and anxiety. In addition, duloxetine is used to help relieve nerve pain (peripheral neuropathy) in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia (a condition that causes widespread pain). Duloxetine may improve your mood, sleep, appetite, and energy level, and decrease nervousness. It can also decrease pain due to certain medical conditions. Duloxetine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). This medication works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Fentanyl

Generic Formulation: FentanylSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 16
30-Day Fills 16.0
Days Supply 480
AK State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills24.8
Peer Average Days Supply686
Conservative Utilization

This provider writes prescriptions for this formulation 33.3% less frequently than the standard regional baseline metric for practitioners inside AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,881.57 across this reporting matrix range.

Provider Avg Cost Per Claim

$117.60

State Avg Cost Per Claim

$99.77

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)

Therapeutic Applications

This medication is used to help relieve severe ongoing pain (such as due to cancer). Fentanyl belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. Do not use the patch form of fentanyl to relieve pain that is mild or that will go away in a few days. This medication is not for occasional (as needed) use.

Gabapentin

Generic Formulation: GabapentinSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 201
30-Day Fills 222.5
Days Supply 6,633
AK State Average Benchmarks
Peer Average Claims52.0
Peer Average 30-Day Fills78.3
Peer Average Days Supply2,155
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 286.5% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,309.17 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.44

State Avg Cost Per Claim

$22.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Hydrocodone-Acetaminophen

Generic Formulation: Hydrocodone/AcetaminophenSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 123
30-Day Fills 124.0
Days Supply 3,405
AK State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills44.7
Peer Average Days Supply886
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 179.5% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,222.84 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.07

State Avg Cost Per Claim

$21.56

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to relieve moderate to severe pain. It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Meloxicam

Generic Formulation: MeloxicamSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 57
30-Day Fills 73.0
Days Supply 2,190
AK State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills44.6
Peer Average Days Supply1,276
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 111.1% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $366.77 across this reporting matrix range.

Provider Avg Cost Per Claim

$6.43

State Avg Cost Per Claim

$8.30

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS.

Therapeutic Applications

Meloxicam is used to help relieve moderate to severe pain. Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling or pain.

Methadone Hcl

Generic Formulation: Methadone HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 15
30-Day Fills 15.0
Days Supply 450
AK State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills32.6
Peer Average Days Supply901
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 53.1% less volume than the regional standard for practitioners inside AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $236.83 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.79

State Avg Cost Per Claim

$15.11

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of MORPHINE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3)

Therapeutic Applications

This medication is used to treat addiction to opioids (such as heroin) as part of an approved treatment program. Methadone belongs to a class of drugs known as opioid analgesics. It helps prevent withdrawal symptoms caused by stopping other opioids.

Methocarbamol

Generic Formulation: MethocarbamolSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 38
30-Day Fills 40.0
Days Supply 1,110
AK State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills22.8
Peer Average Days Supply526
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 81.0% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $321.35 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.46

State Avg Cost Per Claim

$13.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A centrally acting muscle relaxant whose mode of action has not been established. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1206)

Therapeutic Applications

Methocarbamol is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It works by helping to relax the muscles.

Nabumetone

Generic Formulation: NabumetoneSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 25
30-Day Fills 29.0
Days Supply 870
AK State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills21.0
Peer Average Days Supply584
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 38.9% more claims than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $326.81 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.07

State Avg Cost Per Claim

$14.82

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.

Therapeutic Applications

Nabumetone is used to reduce pain, swelling, and joint stiffness from arthritis. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section.

Naproxen

Generic Formulation: NaproxenSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 390
AK State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills25.1
Peer Average Days Supply550
Conservative Utilization

This provider writes prescriptions for this formulation 38.1% less frequently than the standard regional baseline metric for practitioners inside AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $33.49 across this reporting matrix range.

Provider Avg Cost Per Claim

$2.58

State Avg Cost Per Claim

$16.41

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout.

Therapeutic Applications

Naproxen is used to relieve mild to moderate pain from various conditions. It also reduces pain, swelling, and joint stiffness from arthritis. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. This form of naproxen is absorbed slowly and should not be used for pain that needs quick relief (such as during a gout attack). Ask your doctor or pharmacist about using a different form of this drug or other medications for quick relief of pain.

Nortriptyline Hcl

Generic Formulation: Nortriptyline HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 79
30-Day Fills 81.0
Days Supply 2,430
AK State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills28.1
Peer Average Days Supply735
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 295.0% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,143.75 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.48

State Avg Cost Per Claim

$15.91

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat mental/mood problems such as depression. It may help improve mood and feelings of well-being, relieve anxiety and tension, and increase your energy level. This medication belongs to a class of medications called tricyclic antidepressants. It works by affecting the balance of certain natural chemicals (neurotransmitters) in the brain.

Oxycodone Hcl

Generic Formulation: Oxycodone HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 32
30-Day Fills 32.0
Days Supply 901
AK State Average Benchmarks
Peer Average Claims44.0
Peer Average 30-Day Fills45.0
Peer Average Days Supply963
Conservative Utilization

This provider writes prescriptions for this formulation 27.3% less frequently than the standard regional baseline metric for practitioners inside AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $620.69 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.40

State Avg Cost Per Claim

$23.00

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic derivative of CODEINE.

Therapeutic Applications

This medication is used to help relieve moderate to severe pain. Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Oxycodone-Acetaminophen

Generic Formulation: Oxycodone Hcl/AcetaminophenSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 52
30-Day Fills 52.0
Days Supply 1,361
AK State Average Benchmarks
Peer Average Claims39.0
Peer Average 30-Day Fills40.0
Peer Average Days Supply876
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 33.3% more claims than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,678.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$32.29

State Avg Cost Per Claim

$27.77

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to help relieve moderate to severe pain. It contains an opioid pain reliever (oxycodone) and a non-opioid pain reliever (acetaminophen). Oxycodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Pregabalin

Generic Formulation: PregabalinSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 107
30-Day Fills 113.0
Days Supply 3,298
AK State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills39.7
Peer Average Days Supply1,121
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 256.7% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,078.75 across this reporting matrix range.

Provider Avg Cost Per Claim

$28.77

State Avg Cost Per Claim

$49.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA.

Therapeutic Applications

This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures).

Tizanidine Hcl

Generic Formulation: Tizanidine HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 79
30-Day Fills 87.0
Days Supply 2,373
AK State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills38.0
Peer Average Days Supply991
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 154.8% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,631.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.66

State Avg Cost Per Claim

$16.85

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury). It works by helping to relax the muscles.

Topiramate

Generic Formulation: TopiramateSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 21
30-Day Fills 27.0
Days Supply 810
AK State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills42.6
Peer Average Days Supply1,089
Conservative Utilization

This provider writes prescriptions for this formulation 32.3% less frequently than the standard regional baseline metric for practitioners inside AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $395.46 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.83

State Avg Cost Per Claim

$16.81

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A sulfamate-substituted fructose analog that was originally identified as a hypoglycemic agent. It is used for the treatment of EPILEPSY and MIGRAINE DISORDERS, and may also promote weight loss.

Therapeutic Applications

Topiramate is used alone or with other medications to prevent and control seizures (epilepsy). This medication is also used to prevent migraine headaches and decrease how often you get them. Topiramate will not treat a migraine headache once it occurs. If you get a migraine headache, treat it as directed by your doctor (such as by taking pain medication, lying down in a dark room). Topiramate is known as an anticonvulsant or antiepileptic drug.

Tramadol Hcl

Generic Formulation: Tramadol HclSpecialty: Anesthesiology
Provider Metrics Summary
Total Claims 104
30-Day Fills 104.7
Days Supply 2,468
AK State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills33.8
Peer Average Days Supply690
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 215.2% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,114.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.71

State Avg Cost Per Claim

$7.77

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A narcotic analgesic proposed for severe pain. It may be habituating.

Therapeutic Applications

See also Warning section. This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like RENEE MARCHEGIANI DO provides transparency into local medical care patterns within Wasilla, AK.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Pain Medicine** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.